Combining cytotoxic chemotherapy with cyclooxygenase-2 inhibition
- PMID: 12860936
- DOI: 10.1200/JCO.2003.02.044
Combining cytotoxic chemotherapy with cyclooxygenase-2 inhibition
Comment on
-
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.J Clin Oncol. 2003 Jul 15;21(14):2645-50. doi: 10.1200/JCO.2003.07.127. J Clin Oncol. 2003. PMID: 12860939 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
